Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
2.030
-0.010 (-0.49%)
Dec 4, 2025, 4:00 PM EST - Market closed

Mural Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
355599--
Market Cap Growth
-38.65%-44.34%---
Enterprise Value
-20-111115--
Last Close Price
2.043.225.92--
PB Ratio
0.640.390.38--
P/TBV Ratio
0.640.390.38--
Debt / Equity Ratio
0.060.060.06-0.89-1.41
Quick Ratio
5.595.539.550.040.06
Current Ratio
5.905.849.560.120.13
Return on Equity (ROE)
-103.87%-63.57%-171.33%--
Return on Assets (ROA)
-49.05%-36.68%-73.11%-335.69%-
Return on Capital (ROIC)
-54.43%-40.44%-88.70%-4482.33%-
Return on Capital Employed (ROCE)
-191.10%-96.60%-72.00%2367.80%-9413.00%
Earnings Yield
-336.60%-233.67%-209.96%--
FCF Yield
-334.77%-233.89%-200.10%--
Buyback Yield / Dilution
-2.07%-1.59%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q